JP2023524643A5 - - Google Patents
Info
- Publication number
- JP2023524643A5 JP2023524643A5 JP2022563136A JP2022563136A JP2023524643A5 JP 2023524643 A5 JP2023524643 A5 JP 2023524643A5 JP 2022563136 A JP2022563136 A JP 2022563136A JP 2022563136 A JP2022563136 A JP 2022563136A JP 2023524643 A5 JP2023524643 A5 JP 2023524643A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antibody
- tyrosine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063014033P | 2020-04-22 | 2020-04-22 | |
| US63/014,033 | 2020-04-22 | ||
| US202063014549P | 2020-04-23 | 2020-04-23 | |
| US63/014,549 | 2020-04-23 | ||
| PCT/US2021/028548 WO2021216810A1 (en) | 2020-04-22 | 2021-04-22 | Long-acting anti-il31 antibodies for veterinary use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023524643A JP2023524643A (ja) | 2023-06-13 |
| JP2023524643A5 true JP2023524643A5 (enExample) | 2024-05-02 |
Family
ID=78269992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022563136A Pending JP2023524643A (ja) | 2020-04-22 | 2021-04-22 | 獣医学的使用のための長時間作用性抗ｉｌ３１抗体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230312702A1 (enExample) |
| EP (1) | EP4138914A4 (enExample) |
| JP (1) | JP2023524643A (enExample) |
| KR (1) | KR20230005875A (enExample) |
| CN (1) | CN115666644A (enExample) |
| AU (1) | AU2021258198A1 (enExample) |
| BR (1) | BR112022021216A2 (enExample) |
| CA (1) | CA3173864A1 (enExample) |
| MX (1) | MX2022013147A (enExample) |
| WO (1) | WO2021216810A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017189805A1 (en) | 2016-04-27 | 2017-11-02 | Abbvie Inc. | Methods of treatment of diseases in which il-13 activity is detrimental using anti-il-13 antibodies |
| US10093731B2 (en) * | 2017-02-24 | 2018-10-09 | Kindred Biosciences, Inc. | Anti-IL31 antibodies for veterinary use |
| AU2018318440A1 (en) | 2017-08-15 | 2020-02-13 | Kindred Biosciences, Inc. | IgG Fc variants for veterinary use |
| EP3866842A4 (en) * | 2018-10-18 | 2022-07-13 | Kindred Biosciences, Inc. | FC VARIANTS WITH MODIFIED BINDING TO THE NEONATAL FC RECEPTOR (FCRN) FOR VETERINARY USE |
| JP7671275B2 (ja) | 2019-08-29 | 2025-05-01 | エランコ・ユーエス・インコーポレイテッド | 動物用の抗ｉｌ３１抗体 |
| KR20250137204A (ko) * | 2022-12-27 | 2025-09-17 | 인베티엑스 인코포레이티드 | 신생아 fc 수용체(fcrn)에 대한 결합이 변경된 폴리펩타이드 및 사용 방법 |
| GB202405576D0 (en) * | 2024-04-19 | 2024-06-05 | 272Bio Ltd | VHH antibodies |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201920257A (zh) * | 2008-04-11 | 2019-06-01 | 日商中外製藥股份有限公司 | 重複結合複數個抗原的抗原結合分子 |
| EP3526246A1 (en) * | 2016-10-17 | 2019-08-21 | Vetoquinol SA | Modified antibody constant region |
| WO2018156367A1 (en) * | 2017-02-24 | 2018-08-30 | Kindred Biosciences, Inc. | Anti-il31 antibodies for veterinary use |
| US10093731B2 (en) * | 2017-02-24 | 2018-10-09 | Kindred Biosciences, Inc. | Anti-IL31 antibodies for veterinary use |
| AU2018318440A1 (en) * | 2017-08-15 | 2020-02-13 | Kindred Biosciences, Inc. | IgG Fc variants for veterinary use |
| JP7449234B2 (ja) * | 2018-03-16 | 2024-03-13 | ゾエティス・サービシーズ・エルエルシー | 獣医学使用のためのインターロイキン３１モノクローナル抗体 |
| EP3866842A4 (en) * | 2018-10-18 | 2022-07-13 | Kindred Biosciences, Inc. | FC VARIANTS WITH MODIFIED BINDING TO THE NEONATAL FC RECEPTOR (FCRN) FOR VETERINARY USE |
| CN120005022A (zh) * | 2019-01-03 | 2025-05-16 | 因外泰克斯公司 | 用于增加治疗剂在犬中的半衰期的组合物及使用方法 |
| KR20220066002A (ko) * | 2019-03-20 | 2022-05-23 | 킨드레드 바이오사이언시스, 인코포레이티드 | 의학적 용도의 ngf 길항제 |
| US20240067738A1 (en) * | 2020-03-18 | 2024-02-29 | Elanco Us Inc. | Anti-il4 receptor antibodies for veterinary use |
-
2021
- 2021-04-22 CA CA3173864A patent/CA3173864A1/en active Pending
- 2021-04-22 KR KR1020227039975A patent/KR20230005875A/ko active Pending
- 2021-04-22 CN CN202180036332.3A patent/CN115666644A/zh active Pending
- 2021-04-22 JP JP2022563136A patent/JP2023524643A/ja active Pending
- 2021-04-22 WO PCT/US2021/028548 patent/WO2021216810A1/en not_active Ceased
- 2021-04-22 AU AU2021258198A patent/AU2021258198A1/en active Pending
- 2021-04-22 BR BR112022021216A patent/BR112022021216A2/pt unknown
- 2021-04-22 US US17/996,557 patent/US20230312702A1/en active Pending
- 2021-04-22 EP EP21792891.0A patent/EP4138914A4/en active Pending
- 2021-04-22 MX MX2022013147A patent/MX2022013147A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7716441B2 (ja) | 獣医用抗ｉｌ－３１抗体 | |
| JP7657797B2 (ja) | ＴＮＦαおよびＩＬ－２３を標的化する免疫グロブリン単一可変ドメインを含むポリペプチド | |
| JP5738294B2 (ja) | 抗ｖｅｇｆモノクローナル抗体およびその抗体を含む薬学的組成物 | |
| JP2020501583A (ja) | ヒトｉｌ−１５に特異的に結合する抗体及びその使用 | |
| WO2018156367A1 (en) | Anti-il31 antibodies for veterinary use | |
| JP2022545259A5 (enExample) | ||
| US20220185879A1 (en) | IL17A Antibodies and Antagonists for Veterinary Use | |
| CN114555121A (zh) | 兽用抗il31抗体 | |
| JP2023524643A (ja) | 獣医学的使用のための長時間作用性抗ｉｌ３１抗体 | |
| JP2026500341A (ja) | 抗ＩＬ２３及び抗ＴＮＦα抗体：組成物ならびに獣医学的使用 | |
| JP7084057B2 (ja) | 新規抗ｐａｄ２抗体 | |
| WO2026012501A1 (zh) | 一种抗ngf单克隆抗体及其应用 | |
| RU2835543C1 (ru) | Анти-il31 антитела для применения в ветеринарии | |
| RU2795485C2 (ru) | Анти-il31 антитела для применения в ветеринарии | |
| TW202432593A (zh) | 抗體、其抗原結合片段及其藥物用途 |